BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30212566)

  • 1. Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri.
    Zhou W; Debnath A; Jennings G; Hahn HJ; Vanderloop BH; Chaudhuri M; Nes WD; Podust LM
    PLoS Pathog; 2018 Sep; 14(9):e1007245. PubMed ID: 30212566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).
    Debnath A; Calvet CM; Jennings G; Zhou W; Aksenov A; Luth MR; Abagyan R; Nes WD; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006104. PubMed ID: 29284029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA Reductase Inhibitors as Drug Leads against
    Hahn HJ; Abagyan R; Podust LM; Roy S; Ali IKM; Debnath A
    ACS Chem Neurosci; 2020 Oct; 11(19):3089-3096. PubMed ID: 32881478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Growth Rates and
    Russell AC; Kyle DE
    Microbiol Spectr; 2022 Feb; 10(1):e0189921. PubMed ID: 35138140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
    Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
    Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
    Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi.
    Cárdenas-Zúñiga R; Silva-Olivares A; Villalba-Magdaleno JA; Sánchez-Monroy V; Serrano-Luna J; Shibayama M
    Microbiology (Reading); 2017 Jul; 163(7):940-949. PubMed ID: 28721850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri.
    Zysset-Burri DC; Müller N; Beuret C; Heller M; Schürch N; Gottstein B; Wittwer M
    BMC Genomics; 2014 Jun; 15(1):496. PubMed ID: 24950717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-amoebic activity of Pinus densiflora leaf extract against the brain-eating amoeba Naegleria fowleri.
    Lê HG; Kim W; Kang JM; Võ TC; Yoo WG; Cheong H; Na BK
    Parasites Hosts Dis; 2024 May; 62(2):169-179. PubMed ID: 38835258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Amoebic Meningoencephalitis by
    Güémez A; García E
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572533
    [No Abstract]   [Full Text] [Related]  

  • 11. In silico analysis of Naegleria fowleri cathepsin B paralogs: important drug targets.
    Aurongzeb M; Haq SA; Rashid Y; Ahmed Naqvi SH; Hussain SI; Rehman AU; Kaleem I; Bashir S
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3162-3172. PubMed ID: 33928602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterol biosynthesis via cycloartenol and other biochemical features related to photosynthetic phyla in the amoeba Naegleria lovaniensis and Naegleria gruberi.
    Raederstorff D; Rohmer M
    Eur J Biochem; 1987 Apr; 164(2):427-34. PubMed ID: 3569274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba.
    Tillery L; Barrett K; Goldstein J; Lassner JW; Osterhout B; Tran NL; Xu L; Young RM; Craig J; Chun I; Dranow DM; Abendroth J; Delker SL; Davies DR; Mayclin SJ; Calhoun B; Bolejack MJ; Staker B; Subramanian S; Phan I; Lorimer DD; Myler PJ; Edwards TE; Kyle DE; Rice CA; Morris JC; Leahy JW; Manetsch R; Barrett LK; Smith CL; Van Voorhis WC
    PLoS One; 2021; 16(3):e0241738. PubMed ID: 33760815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China.
    Zhang LL; Wu M; Hu BC; Chen HL; Pan JR; Ruan W; Yao LN
    Int J Infect Dis; 2018 Jul; 72():28-33. PubMed ID: 29751112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Genomic and Transcriptomic Analysis of Naegleria fowleri Clinical and Environmental Isolates.
    Joseph SJ; Park S; Kelley A; Roy S; Cope JR; Ali IKM
    mSphere; 2021 Aug; 6(4):e0063721. PubMed ID: 34378985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual Screening of Alkaloid and Terpenoid Inhibitors of SMT Expressed in
    Abraham J; Chauhan N; Ray S
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of
    Shi D; Chahal KK; Oto P; Nothias LF; Debnath A; McKerrow JH; Podust LM; Abagyan R
    ACS Infect Dis; 2019 Dec; 5(12):2029-2038. PubMed ID: 31583882
    [No Abstract]   [Full Text] [Related]  

  • 18. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
    Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.
    Debnath A
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1099-1106. PubMed ID: 33496193
    [No Abstract]   [Full Text] [Related]  

  • 20. Excretory and Secretory Proteins of Naegleria fowleri Induce Inflammatory Responses in BV-2 Microglial Cells.
    Lee J; Kang JM; Kim TI; Kim JH; Sohn HJ; Na BK; Shin HJ
    J Eukaryot Microbiol; 2017 Mar; 64(2):183-192. PubMed ID: 27480446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.